4//SEC Filing
Sniecinski Megan 4
Accession 0001127602-19-023901
CIK 0000882796other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:25 PM ET
Size
5.2 KB
Accession
0001127602-19-023901
Insider Transaction Report
Form 4
Sniecinski Megan
Chief Business Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2019-07-01+500,000→ 500,000 totalExercise: $3.71From: 2020-07-01Exp: 2029-07-01→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]Inducement option grant becomes exercisable at the rate of 30% on the first anniversary of the grant date with the remainder vesting in three equal installments on the second, third and fourth anniversaries of the grant date.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001781480
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 1:25 PM ET
- Size
- 5.2 KB